Fig. 1. Gilteritinib reduces FLT3 expression. (A) Western blot analysis of FLT3 and p-FLT3 expression in MOLM-14 cells treated with different concentrations of gilteritinib for 24 h. β-Actin was used as a loading control. (B) Western blot analysis of FLT3 and p-FLT3 expression in MOLM-14 cells treated with 1 μM gilteritinib for the indicated time. β-Actin was used as a loading control.
© Biomolecules & Therapeutics
